Evidence map›Paper›PMID 41694731›Full record

ArticlePerspectives in clinical research

Measuring quality of life in clinical research - Part 3.

Dagmara Kuliś, Priya Ranganathan, C S Pramesh, Jammbe Z Musoro

Abstract read
In one paragraph

Article in Perspectives in clinical research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Dagmara KuliśEuropean Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.
Priya RanganathanDepartment of Anaesthesiology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
C S PrameshDepartment of Thoracic Surgery, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
Jammbe Z MusoroEuropean Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Health-related quality of life (HRQoL) is an important outcome in cancer research, as it captures the impact of disease and treatment on patients' daily functioning and well-being. Building on earlier discussions of HRQOL concepts and measurement methods, this article focuses on HRQoL issues specific to patients with cancer and highlights key European Organisation for Research and Treatment of Cancer resources for HRQoL research in oncology.

Indexed as

Health-related quality of lifeHRQOLquality of life

Identifiers

PMID41694731
PMCPMC12900397

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.